| Description | Sovaprevir is a non-structural 3 (NS3) protease inhibitor with antiviral activity for the treatment of HCV infection. |
| Synonyms | ACH 0141625, ACH0141625, ACH-0141625, ACH1625, ACH 1625, ACH-1625 |
| molecular weight | 799.97 |
| Molecular formula | C43H53N5O8S |
| CAS | 1001667-23-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 25 mg/mL (31.25 mM) |
| References | 1. Vere Hodge RA. Meeting report: 26th International Conference on Antiviral Research. Antiviral Res. 2013 ; 100(1):276-285. 2. De Clercq E. Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochem Pharmacol. 2014 ; 89(4):441-452. 3. Behloul N, et al. In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain. Eur J Pharmacol. 2021 ; 890:173701. |